---
title: "Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), all indications: Safety questions"
description: "Safety questions on Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Side effects and Warnings. Questions: Which side effects have been reported after Gardasil 9 approval? Who should not get Gardasil 9 (contraindications)? Can Gardasil 9 cause fainting (syncope)? What precautions apply for allergic reactions to Gardasil 9? 2 further questions follow. 6 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/gardasil-9/safety"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), all indications: Safety questions

Manufacturer: Merck Sharp & Dohme LLC  
Prescribing information: [Gardasil 9](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf)  
Indication pages: [Human papillomavirus vaccination](https://www.evicenter.com/medical-information/gardasil-9--human-papillomavirus-vaccination)

## Side effects

<a id="gardasil9-postmarketing-side-effects"></a>

### Which side effects have been reported after Gardasil 9 approval?

> “The postmarketing adverse experiences were reported voluntarily from a population of uncertain size,
> therefore, it is not possible to reliably estimate their frequency or to establish a causal relationship to
> vaccine exposure.”

Source: [GARDASIL 9: Prescribing information, page 9, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=9)

> “The safety profile of GARDASIL 9 and GARDASIL are similar. The postmarketing safety experience
> with GARDASIL is relevant to GARDASIL 9 since the vaccines are manufactured similarly and contain the
> same L1 HPV proteins of four of the same HPV types.”

Source: [GARDASIL 9: Prescribing information, page 9, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=9)

> “In addition to the adverse reactions reported in the clinical studies, the following adverse experiences
> have been spontaneously reported during post-approval use of GARDASIL 9:
> Gastrointestinal disorders: Vomiting.
> Skin and subcutaneous tissue disorders: Urticaria.
> General disorders and administration site conditions: Injection-site nodule.”

Source: [GARDASIL 9: Prescribing information, page 9, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=9)

## Warnings

<a id="gardasil9-contraindications"></a>

### Who should not get Gardasil 9 (contraindications)?

> “Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous
> dose of GARDASIL 9 or GARDASIL [see Description (11)].”

Source: [GARDASIL 9: Prescribing information, page 3, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=3)

<a id="gardasil9-fainting"></a>

### Can Gardasil 9 cause fainting (syncope)?

> “Because vaccinees may develop syncope, sometimes resulting in falling with injury, observation for
> 15 minutes after administration is recommended. Syncope, sometimes associated with tonic-clonic
> movements and other seizure-like activity, has been reported following HPV vaccination. When syncope
> is associated with tonic-clonic movements, the activity is usually transient and typically responds to
> restoring cerebral perfusion by maintaining a supine or Trendelenburg position.”

Source: [GARDASIL 9: Prescribing information, page 3, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=3)

<a id="gardasil9-allergic-reactions"></a>

### What precautions apply for allergic reactions to Gardasil 9?

> “Appropriate medical treatment and supervision must be readily available in case of anaphylactic
> reactions following the administration of GARDASIL 9.”

Source: [GARDASIL 9: Prescribing information, page 4, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=4)

## Safety

<a id="gardasil9-report-side-effects"></a>

### How do I report a Gardasil 9 side effect?

> “To report SUSPECTED ADVERSE REACTIONS, contact Merck
> Sharp 
> & 
> Dohme 
> LLC 
> at 
> 1-877-888-4231 
> or 
> VAERS 
> at
> 1-800-822-7967 or www.vaers.hhs.gov”

Source: [GARDASIL 9: Prescribing information, page 1, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=1)

<a id="gardasil9-fertility"></a>

### Does Gardasil 9 affect fertility?

> “Developmental toxicity studies were conducted in female rats. In one study, animals were
> administered 0.5 mL of a vaccine formulation containing between 1 and 1.5 –fold of each of the 9 HPV
> antigen types 5 and 2 weeks prior to mating, and on gestation day 6. In a second study, animals were
> administered a single human dose (0.5 mL) of GARDASIL 9, 5 and 2 weeks prior to mating, on gestation
> day 6, and on lactation day 7. No adverse effects on pre- and post-weaning development were observed.
> There were no vaccine-related fetal malformations or variations, or effects on female fertility.”

Source: [GARDASIL 9: Prescribing information, page 11, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=11)

> “GARDASIL 9 has not been evaluated for the potential to cause carcinogenicity, genotoxicity or
> impairment of male fertility.”

Source: [GARDASIL 9: Prescribing information, page 12, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=12)

## Related pages
- [Medical information: Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant): All indications](https://www.evicenter.com/medical-information/gardasil-9)
- [Indication](https://www.evicenter.com/medical-information/gardasil-9/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/gardasil-9/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/gardasil-9/clinical-trials)
- [Specific populations](https://www.evicenter.com/medical-information/gardasil-9/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/gardasil-9/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/gardasil-9/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/gardasil-9/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/gardasil-9/access-and-coverage)
